Data from Ongoing Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Safety and Clinical Activity, Validate Differentiated Strategy
September 28, 2014Clovis Oncology announced preliminary Phase 2 results from the ARIEL2 study and updated results from the ongoing Phase 1/2 monotherapy study of rucaparib, the company's investigational small molecule inhibitor to treat platinum-sensitive ovarian cancer.
More »
Zyga Technology Completes $10 Million Financing
September 25, 2014Zyga Technology, Inc., announced the completion of a $10 million round of financing and intends to use the proceeds to fund the expansion of its sales and marketing organization preparing for the implementation of a Category 1 CPT code in January 2015.
More »
Meritage Pharma Announces Positive Results of Oral Budesonide Suspension for Treatment of Eosinophilic Esophagitis in Adolescent and Adult Patients
September 25, 2014Meritage Pharma announced positive Phase 2b results of oral budesonide suspension (OBS) for the treatment of adolescents and adults with eosinophilic esophagitis (EoE).
More »